Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M22,456Revenue (TTM) $M1,557Net Margin (%)-17.7Altman Z-Score6.4
Enterprise Value $M22,393EPS (TTM) $-1.1Operating Margin %-8.7Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.7Pre-tax Margin (%)-13.9Higher ROA y-yY
Price/Book22.910-y EBITDA Growth Rate %--Quick Ratio2.2Cash flow > EarningsY
Price/Sales14.15-y EBITDA Growth Rate %--Current Ratio2.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-11.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-29.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M248ROIC % (ttm)-15.0Gross Margin Increase y-yN

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXJoel Greenblatt 2016-06-30 Add0.1%$79.15 - $96.09
($86.3)
$ 90.635%Add 2053.31%108,656
VRTXJohn Paulson 2016-06-30 Sold Out -0.04%$79.15 - $96.09
($86.3)
$ 90.635%Sold Out0
VRTXLeucadia National 2016-06-30 Sold Out -0.04%$79.15 - $96.09
($86.3)
$ 90.635%Sold Out0
VRTXVanguard Health Care Fund 2016-06-30 Add0.04%$79.15 - $96.09
($86.36)
$ 90.635%Add 1.95%12,914,741
VRTXGeorge Soros 2016-06-30 Buy 0.02%$79.15 - $96.09
($86.3)
$ 90.635%New holding6,300
VRTXKen Fisher 2016-06-30 Reduce$79.15 - $96.09
($86.3)
$ 90.635%Reduce -0.83%5,112
VRTXVanguard Health Care Fund 2016-03-31 Add0.5%$78.4 - $125.83
($91.01)
$ 90.63-0%Add 28.91%12,668,241
VRTXLeucadia National 2016-03-31 Buy 0.04%$78.4 - $125.83
($91.01)
$ 90.63-0%New holding3,300
VRTXJoel Greenblatt 2016-03-31 Reduce-0.01%$78.4 - $125.83
($91.01)
$ 90.63-0%Reduce -57.21%5,046
VRTXJohn Paulson 2016-03-31 Add0.01%$78.4 - $125.83
($91.01)
$ 90.63-0%Add 32.54%61,500
VRTXKen Fisher 2016-03-31 Reduce$78.4 - $125.83
($91.01)
$ 90.63-0%Reduce -7.00%5,155
VRTXVanguard Health Care Fund 2015-12-31 Add0.1%$109.03 - $133.26
($121.16)
$ 90.63-25%Add 4.34%9,827,411
VRTXJohn Paulson 2015-12-31 Buy 0.04%$109.03 - $133.26
($121.16)
$ 90.63-25%New holding46,400
VRTXJoel Greenblatt 2015-12-31 Buy 0.02%$109.03 - $133.26
($121.16)
$ 90.63-25%New holding11,793
VRTXKen Fisher 2015-12-31 Add$109.03 - $133.26
($120.93)
$ 90.63-25%Add 12.48%5,543
VRTXVanguard Health Care Fund 2015-09-30 Reduce-0.03%$98.5 - $141.48
($128.47)
$ 90.63-29%Reduce -1.21%9,418,411
VRTXKen Fisher 2015-09-30 Add$98.5 - $141.48
($128.47)
$ 90.63-29%Add 12.56%4,928
VRTXGeorge Soros 2015-06-30 Sold Out -0.07%$116.43 - $135.82
($125.88)
$ 90.63-28%Sold Out0
VRTXKen Fisher 2015-06-30 Reduce$116.43 - $135.82
($125.88)
$ 90.63-28%Reduce -0.18%4,378
VRTXVanguard Health Care Fund 2015-03-31 Reduce-0.08%$107.88 - $134.25
($119.81)
$ 90.63-24%Reduce -2.80%9,533,911
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BOGER JOSHUA SDirector 2016-09-21Sell6,500$90.82-0.21view
BOGER JOSHUA SDirector 2016-09-14Sell6,500$92.37-1.88view
BOGER JOSHUA SDirector 2016-09-07Sell6,500$95.66-5.26view
BOGER JOSHUA SDirector 2016-08-31Sell6,500$94.62-4.22view
BOGER JOSHUA SDirector 2016-08-24Sell7,500$100.46-9.78view
BOGER JOSHUA SDirector 2016-08-22Sell1,100$100.79-10.08view
BOGER JOSHUA SDirector 2016-08-17Sell6,900$99.63-9.03view
BOGER JOSHUA SDirector 2016-08-11Sell900$100.19-9.54view
BOGER JOSHUA SDirector 2016-08-10Sell7,100$100.24-9.59view
BOGER JOSHUA SDirector 2016-08-03Sell47,000$100.66-9.96view

Quarterly/Annual Reports about VRTX:

    News about VRTX:

    Articles On GuruFocus.com
    Edward Owens Top 2nd Quarter Investments Aug 03 2016 
    Vanguard Health Care Fund Ups Stake in High-Conviction Stocks May 10 2016 
    Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
    Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
    Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter May 20 2015 
    Analysts Confident That Vertex Pharmaceuticals' CF Drug Will Receive FDA Approval May 13 2015 
    Fate Of Cystic Fibrosis Drug By Vertex Is Now Dependent On FDA Approval May 13 2015 
    J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
    William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
    Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex Pharmaceutica Nov 09 2014 

    More From Other Websites
    [$$] Chilled Vertex Could Heat Up Quickly Sep 20 2016
    Buy Allows Horizon to Further Expand into Orphan Drug Space Sep 20 2016
    [$$] Chilled Vertex Could Heat Up Quickly Sep 20 2016
    M&A: Acquirers Love Dividends Too Sep 19 2016
    Vertex: Did Management Deliver Investors a Backhanded Slap? Sep 16 2016
    [$$] Vertex Looks to Cash In On Its Rich Drug Pipeline Sep 16 2016
    Vertex: News Creates Opportunity in Shares Sep 14 2016
    Why Vertex Pharmaceuticals is Tanking Sep 14 2016
    Vertex Pharma stock drops 5% after company predicts slower Q3 Sep 14 2016
    Vertex Pharmaceuticals, Inc. – Value Analysis (NASDAQ:VRTX) : September 14, 2016 Sep 14 2016
    Vertex Stock Tumbles Sep 14 2016
    Key FDA Decisions and Trial Results Coming in the Next 2 Months Sep 14 2016
    Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US :... Sep 13 2016
    Coverage initiated on Vertex Pharma by Raymond James Sep 13 2016
    Vertex to Present at Upcoming Investor Conferences Sep 09 2016
    Vertex to Present at Upcoming Investor Conferences Sep 09 2016
    3 Biotech Stocks That Could Make Big Moves In September Sep 02 2016
    Biotech Stocks: Look At Those Takeover Premiums! Sep 01 2016
    Zacks.com featured highlights: Covanta Holding, ZELTIQ Aesthetics, Capital Senior Living, Live... Aug 31 2016
    Biotech Stocks: Oops, She Did It Again Aug 25 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)